Increased post-operative complications with methylene blue versus lymphazurin in sentinel lymph node biopsies for skin cancers

Journal of Surgical Oncology

Volumn 103, Issue 5, 2011, Pages 421-425

  Neves, Rogerio I ^a   Reynolds, Brandon Q ^a   Hazard, Sprague W ^a   Saunders, Brian ^a   Mackay, Donald R ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Blue dye; Lymphazurin; Melanoma; Sentinel lymph node biopsy; Skin cancers

Indexed keywords

ANTIBIOTIC AGENT; ISOSULFAN BLUE; METHYLENE BLUE;

ANAPHYLAXIS; ARTICLE; BLISTER; CANCER LOCALIZATION; CANCER PATIENT; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; RELIABILITY; SENTINEL LYMPH NODE BIOPSY; SKIN CANCER; SKIN EXFOLIATION; SKIN INFECTION; SKIN TRANSPLANTATION; TATTOOING; UNITED STATES; WOUND DEHISCENCE;

CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; COLORING AGENTS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; METHYLENE BLUE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; STANDARD OF CARE;

EID: 79952600250     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21845     Document Type: Article

References (27)

1. Wagman LD: Principles of surgical oncology. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, editors. Cancer management: A multidisciplinary approach. New York, NY: CMP United Business Media; 2008.
2. Tanis PJ, Nieweg OE, Valdes Olmos RA, et al.: History of sentinel node and validation of the technique. Breast Cancer Res 2001;3:109-112. (Pubitemid 32266279)
3. Morton DL, Cochran AJ, Thompson JF, et al.: Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005;242:302-311; discussion 311-303.
4. Tsopelas C, Sutton R: Why certain dyes are useful for localizing the sentinel lymph node. J Nucl Med 2002;43:1377-1382.
5. Scherer K, Studer W, Figueiredo V, et al. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: Case report and reviewof the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 2006;96:497-500.
6. Efron P, Knudsen E, Hirshorn S, et al. Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: Case report and literature review. Breast J 2002;8:396-399. (Pubitemid 35334660)
7. Cimmino VM, Brown AC, Szocik JF, et al.: Allergic reactions to isosulfan blue during sentinel node biopsy-a common event. Surgery 2001;130:439-442. (Pubitemid 32868455)
8. Liu Y, Truini C, Ariyan S: A randomized study comparing the effectiveness of methylene blue dye with lymphazurin blue dye in sentinel lymph node biopsy for the treatment of cutaneous melanoma. Ann Surg Oncol 2008;15:2412-2417.
9. Komenaka IK, Bauer VP, Schnabel FR, et al.: Allergic reactions to isosulfan blue in sentinel lymph node mapping. Breast J 2005;11:70-72. (Pubitemid 40209349)
10. Albo D, Wayne JD, Hunt KK, et al.: Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:393-398. (Pubitemid 33079094)
11. Leong SP, Donegan E, Heffernon W, et al.: Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000;7:361-366. (Pubitemid 30397478)
12. Simmons RM, Smith SM, Osborne MP: Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Breast J 2001;7:181-183. (Pubitemid 32619780)
13. Thevarajah S, Huston TL, Simmons RM: A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005;189:236-239. (Pubitemid 40255120)
14. Varghese P, Abdel-Rahman AT, Akberali S, et al.: Methylene blue dye - A safe and effective alternative for sentinel lymph node localization. Breast J 2008;14:61-67.
15. Zakaria S, Hoskin TL, Degnim AC: Safety and, technical success of methylene blue dye for lymphatic mapping in breast cancer. Am J Surg 2008;196:228-233. (Pubitemid 351970501)
16. Wilke LG, McCall LM, Posther KE, et al.: Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500.
17. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398; discussion 398-401.
18. Bauer TW, Spitz FR, Callans LS, et al.: Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann Surg Oncol 2002;9:169-176. (Pubitemid 34259704)
19. Cox CE, Salud CJ, Harrinton MA: The role of selective sentinel lymph node dissection in breast cancer. Surg Clin North Am 2000;80:1759-1777. (Pubitemid 32006391)
20. Johnson PC, Sheppeck R: The dark side of methylene blue. Plast Reconstr Surg 1989;83:1076-1077.
21. Perry PM, Meinhard E: Nectotic subcutaneous abscesses following injections of methylene blue. Br J Clin Pract 1974;28:289-291.
22. Brownstein S, Liszauer AD, Jackson WB: Ocular complications of a topical methylene blue-vasoconstrictor-anesthetic preparation. Can J Ophthalmol 1989;24:317-324. (Pubitemid 20083787)
23. Chang YS, Tseng SY, Tseng SH, et al.: Comparison of dyes for cataract surgery. Part 1. Cytotoxicity to corneal endothelial cells in a rabbit model. J Cataract Refract Surg 2005;31:792-798.
24. Stradling B, Aranha G, Gabram S: Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg 2002;184:350-352. (Pubitemid 35287358)
25. Bleicher RJ, Kloth DD, Robinson D, et al. Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy. J Surg Oncol 2009;99:356-360.
26. Salhab M, Al Sarakbi W, Mokbel K: Skin and, fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. Int Semin Surg Oncol 2005;2:26.
27. Kirszberg C, Rumjanek VM, Capella MA: Methylene blue is more toxic to erythroleukemic cells than to normal peripheral blood mononuclear cells: A possible use in chemotherapy. Cancer Chemother Pharmacol 2005;56:659-665. (Pubitemid 41425064)